CJMB vs ZBH · rev $5.7M vs P/E 23, rev $4.26B
Callan JMB Inc. Common Stock (CJMB) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Callan JMB Inc. Common Stock (CJMB) is a integrated freight & logistics company listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported CJMB revenue for 2025-12-31 was $5.7M. Net income was -$8.0M. Revenue was down 12.8% from 2024-12-31 to 2025-12-31. CJMB currently screens at market cap $4.1M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
CJMB currently screens at market cap $4.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the CJMB and ZBH stock pages for the full models.
Not investment advice.